Section Arrow
ENLV.NASDAQ
- Enlivex Ltd
(Financial Status)
Quotes are at least 15-min delayed:2026/07/11 16:45 EDT
Regular Hours
Last
 6.86
-0.54 (-7.30%)
Day High 
7.4 
Prev. Close
7.4 
1-M High
11.025 
Volume 
96.54K 
Bid
2.7
Ask
7.04
Day Low
6.51 
Open
7.4 
1-M Low
6.4155 
Market Cap 
124.56M 
Currency 美元 
P/E 0.02 
%Yield -- 
10-SMA 7.99 
20-SMA 8.82 
50-SMA 10.45 
52-W High 31.5 
52-W Low 6.4155 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
382.20/-1.35
Enterprise Value
124.94M
Balance Sheet
Book Value Per Share
114.96
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABPmgc Holdings Inc1.12+0.06+5.66%-- 
RXRXRecursion Pharmaceuticals3.56-0.2-5.32%-- 
VYNEVYNE Therapeutics0.6376-0.0344-5.12%-- 
HUMAHumacyte0.6937-0.0066-0.94%-- 
GOSSGossamer Bio0.1697-0.0053-3.03%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.